Divalproex Sodium Tablet, Delayed Release
Product Images NDC 29300-140
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 29300-140). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Unichem Pharmaceuticals (usa), Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (674e58bd F580 4805 A7e2 Febcaa37bca5 02)
Image (674e58bd F580 4805 A7e2 Febcaa37bca5 03)
Image (674e58bd F580 4805 A7e2 Febcaa37bca5 04)
Image (674e58bd F580 4805 A7e2 Febcaa37bca5 05)
Image (8e888ed9 2d55 4e95 Ba7b 8b437481c947 1830 2)
Divalproex Sodium Delayed Release Tablets Usp, 125 mg-100t (674e58bd F580 4805 A7e2 Febcaa37bca5 06)
Divalproex Sodium Delayed Release Tablets Usp, 250 mg-100t (674e58bd F580 4805 A7e2 Febcaa37bca5 07)
Divalproex Sodium Delayed Release Tablets Usp, 500 mg-100t (674e58bd F580 4805 A7e2 Febcaa37bca5 08)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.